176 related articles for article (PubMed ID: 36223304)
1. Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamide.
Hsu YO; Hsieh TS; Huang PW; Chu CY
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e246-e248. PubMed ID: 36223304
[No Abstract] [Full Text] [Related]
2. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
3. A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome.
Kim JY; Sohn KH; Song WJ; Kang HR
Acta Derm Venereol; 2013 Nov; 93(6):753-4. PubMed ID: 23584150
[No Abstract] [Full Text] [Related]
4. Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
Prescrire Int; 2015 Jun; 24(161):153. PubMed ID: 26436167
[TBL] [Abstract][Full Text] [Related]
5. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
6. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
7. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug.
Endo Y; Oka A; Uehara A; Toki S; Motegi SI; Ishikawa O; Miyazawa Y; Suzuki K
J Dermatol; 2020 Oct; 47(10):e359-e360. PubMed ID: 32662533
[No Abstract] [Full Text] [Related]
8. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
Miyagawa F; Hasegawa A; Imoto K; Ogawa K; Kobayashi N; Ito K; Fujita H; Aihara M; Watanabe H; Sueki H; Tohyama M; Asada H
Eur J Dermatol; 2015; 25(1):87-9. PubMed ID: 25547780
[No Abstract] [Full Text] [Related]
10. Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
Osawa K; Kiniwa Y; Shimosato Y; Midorikawa H; Shirai T; Sano T; Nakamura K; Okuyama R
Acta Derm Venereol; 2022 May; 102():adv00723. PubMed ID: 35578821
[No Abstract] [Full Text] [Related]
11. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of severe drug hypersensitivity.
Dodiuk-Gad RP; Laws PM; Shear NH
Semin Cutan Med Surg; 2014 Mar; 33(1):2-9. PubMed ID: 25037253
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
14. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
[TBL] [Abstract][Full Text] [Related]
15. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
[TBL] [Abstract][Full Text] [Related]
16. Severe cutaneous adverse reactions to drugs.
Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O
Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287
[TBL] [Abstract][Full Text] [Related]
17. Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.
Lehloenya RJ; Isaacs T; Nyika T; Dhana A; Knight L; Veenstra S; Peter J
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):582-584.e1. PubMed ID: 32835874
[No Abstract] [Full Text] [Related]
18. [HLA-B58.01 and allopurinol hypersensitivity renal vasculitis in a Chinese patient].
Mariette F; Scarfoglière V; Giot M; Basire A; Rouby F; Daniel L; Jourde-Chiche N
Rev Med Interne; 2022 Jul; 43(7):436-439. PubMed ID: 35606203
[TBL] [Abstract][Full Text] [Related]
19. [Severe cutaneous drug reactions in children].
Mockenhaupt M
Hautarzt; 2017 Oct; 68(10):803-814. PubMed ID: 28932875
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
Miyagawa A; Adachi T; Kobayashi Y; Takamiyagi S; Arakawa H; Futatsugi K; Inazumi T
J Dermatol; 2022 Mar; 49(3):e102-e103. PubMed ID: 34837271
[No Abstract] [Full Text] [Related]
[Next] [New Search]